Health Research Area


Biological Matrix


Age Ranges of Participants


Type of CHEAR Lab Analysis


Project List

Perfluoroalkyl and Polyfluroalkyl Substances (PFAS), Protein Biomarkers, Adiposity and Cardiometabolic Risk Factors in a 3-year Cohort of Low-Income Latino Children with Overweight and Obesity from the Stanford GOALS Randomized Controlled Trial

This project will investigate the relationships between plasma perfluoroalkyl and polyfluoroalkyl substances (PFAS), protein biomarkers and adiposity and cardiometabolic risk factors among low-income primarily Latino children from the Stanford GOALS trial. Stanford GOALS was a randomized controlled trial of a community-based, multi-level, multi-component, multi-setting weight control intervention versus health education for body mass index change. The participants were 7-11 year old children living in the San Francisco Bay Area, California at baseline with overweight and obesity (BMI=85th percentile for age and sex on the 2000 CDC growth references). Enrollment occurred in 2012-13 and participants were followed annually for 3-4 years with extremely high follow-up rates. We will examine cross-sectional and longitudinal associations of PFAS concentrations and protein biomarkers with cross-sectional and longitudinal measures of adiposity and risks for cardiovascular disease and type 2 diabetes mellitus.

PI(s): Thomas Robinson, MD, MPH, Stanford University

CHEAR Lab(s): Minnesota CHEAR Exposure Assessment Hub

Related website and publications:
Maternal and Developmental Risks from Environmental and Social Stressors (MADRES)

The approved CHEAR project focuses on 250 participants from the Maternal and Developmental Risks from Environmental and Social Stressors (MADRES) study, which is a low-income predominately Hispanic pregnancy cohort in Los Angeles that was designed to evaluate the impacts of early life exposures to stress and environmental contaminants on obesity risk. The MADRES study began in 2015. Women and their infants are followed from early pregnancy through the first year of life. The objective of the approved CHEAR project is to investigate the impacts of prenatal metal mixture exposures on newborn methylation patterns and birth weight, an important risk factor for long-term health. The University of Michigan CHEAR Lab Hub will measure a panel of 21 metals in 1st and 3rd trimester urine samples and will additionally measure the cord blood CD4+ methylome, using whole genome bisulfite sequencing, in a smaller subset of participants (N = 30).

PI(s): Carrie Breton, ScD, University of Southern California

CHEAR Lab(s): M-CHEAR: Michigan Children's Health Exposure Analysis Resource Laboratory Hub

Related website and publications:
SEARCH for Diabetes in Youth (SEARCH)

SEARCH for Diabetes in Youth (SEARCH) is an on-going, large, culturally diverse, multi-center and population-based epidemiological study of youth (ages 0-19) with diabetes. Initiated in 2000, SEARCH was designed to estimate the prevalence, incidence and clinical presentation of diabetes in youth age < 20 years. Beginning in 2002, SEARCH recruited a series of incident cohorts. Cohort study participants complete longitudinal surveys, physical and laboratory assessments. SEARCH includes 5 clinical sites, including geographic-based sites located in Ohio (8 counties), the state of Colorado, Washington (5 counties), the state of South Carolina, and a health plan site in California (enrollees from 7 counties). The CHEAR-supported ancillary study in SEARCH builds on previously collected phenotype data, assayed samples, and the availability of stored serum for evaluating the association between PFCs and metabolomic changes in youth diagnosed with diabetes. Metabolites identified will be evaluated in association with known cardiovascular disease risk factors.

PI(s): Elizabeth Jensen, PhD, Wake Forest School of Medicine

CHEAR Lab(s): The National Exposure Assessment Laboratory at Emory

Related website and publications:
Domestic Indoor PM and Childhood Asthma Morbidity (DISCOVER Study)

The overall objectives of our CHEAR project are to assess pediatric exposures of non-persistent endocrine disrupting chemicals, including environmental phenols, phthalates, and organophosphate flame retardants, and their effects on respiratory health. We will address our aims using data from two prospective studies enriched with low-income African American children in Baltimore, MD. DISCOVER is a panel study of 180 children aged 5-12 years (100 atopic asthmatic, 50 non-atopic asthmatic, 30 non-asthmatic) enrolled from 2009 to 2013. We conducted daily assessments for each participant during four separate, 7-day home visits spaced approximately 3 months apart. Biospecimens were collected twice during each of the home visits. AIRWEIGHS is an ongoing randomized controlled trial of 200 children aged 5-17 years with persistent asthma (approximately half normal weight, half overweight/obese) that began enrollment in 2016. Children participate in a baseline clinic visit, a 7-day home visit before randomization to a 12-week air purifier intervention, and two additional clinic visits where urine samples are being collected.

PI(s): Lesiam Quiros-Alcala, PhD, Johns Hopkins University

CHEAR Lab(s): M-CHEAR: Michigan Children's Health Exposure Analysis Resource Laboratory Hub

Related website and publications:
Evaluation of Environmental Exposures in TEDDY

The Environmental Determinants of Diabetes in the Young (TEDDY) is a multicenter prospective cohort study that started in 2004 and is following 8,676 children at increased genetic risk enrolled before 3 months of age and followed to 15 years of age in order to identify genetic and environmental triggers of type 1 diabetes (T1D) including infectious agents, dietary, and psychosocial factors. The TEDDY study is comprised of six clinical center in the United States, Germany, Finland, and Sweden. TEDDY designed two nested case-control studies, which include children who have developed islet autoantibodies or have been diagnosed with T1D, and their age-matched controls. TEDDY seeks to test the hypothesis that there are differences between cases and controls in trace elements, cytokine and chemokine levels, urinary phthalate metabolite concentrations, and urinary phenols.

PI(s): Jefferey Krischer, PhD, University of South Florida

CHEAR Lab(s): The National Exposure Assessment Laboratory at Emory, Minnesota CHEAR Exposure Assessment Hub, Mount Sinai CHEAR Network Laboratory Hub

Related website and publications:
Denver Asthma Panel Study-CHEAR Ancillary Study

Urban environments are a poorly understood toxic environment for children with asthma. In order to develop effective therapies and interventions, improved characterization of exposures and exposure-health outcome relationships is needed. The Denver Asthma Panel Study (DAPS), which began in 2014, is the parent study for this CHEAR project. The goal of DAPS was to investigate the relationships between asthma-relevant environmental exposures and asthma severity in an urban cohort of children, ages 8-16 years, with exacerbation-prone asthma. Personal and bedroom environmental exposures (particulate matter < 10 µm in diameter, ozone, and nitrogen dioxide) and asthma severity outcomes (lung function, exacerbations, inflammation, and control) were measured seasonally over the course of one year in the Denver metro area. A total of 68 participants were enrolled: 56 exacerbation-prone asthmatics and 12 control participants without allergies or asthma. Combined, the participants were 35 female, 69 Latino/Hispanic, 10 American Indian/Alaskan Native, 1 Asian, 19 Black/African American, 46 white, and 13 more than one race. The median age and annual household income was 11 years and $20,000–$24,999, respectively. The goal of our proposed CHEAR study is to expand our investigation of how asthma-relevant exposures (tobacco smoke, polycyclic aromatic hydrocarbons, phthalates, volatile organic compounds, and other exposure-related metabolites) impact asthma severity and biological responses (oxidative stress, cytokines, inflammatory markers, and other related metabolites).

PI(s): Andrew Liu, MD, Children's Hospital Colorado

CHEAR Lab(s): The National Exposure Assessment Laboratory at Emory, Minnesota CHEAR Exposure Assessment Hub

Related website and publications:
Biological Responses to Tobacco Smoke Exposure in Ill Children: Inflammatory Processes and Oral Metabolomic Profiles

This CHEAR project will leverage an ongoing, two-group randomized controlled trial (R01HD083354) that compares the efficacy of a tobacco cessation intervention to an active control condition on smoking caregivers who bring their children to the pediatric emergency department.  Participants are 0-17 years of age, nonsmokers, and have a potentially tobacco smoke related illness at baseline. All participants have varying levels of smoke exposure and live in the tristate area of southern Ohio, Indiana, or Kentucky. The sample is approximately 56% African American, 33% White, and 11% other races; sex is equally distributed. Recruitment began in April 2016. The CHEAR project will use sensitive LCMS techniques to analyze cotinine, a measure of tobacco smoke exposure, in child saliva samples collected from ill children at baseline and six-weeks after baseline. Investigators will explore the associations between different levels of tobacco smoke exposure and a broad range of biological outcomes associated with immune system dysregulation based on biomarkers of inflammatory responses and findings from targeted and untargeted metabolomics.

PI(s): Melinda Mahabee-Gittens, MD, Cincinnati Children's Hospital Medical Center

CHEAR Lab(s): The National Exposure Assessment Laboratory at Emory, Minnesota CHEAR Exposure Assessment Hub

Related website and publications:
Investigating Overweight/Obesity and Poor Diet as Susceptibility Factors for Secondhand Smoke in Childhood Asthma

Low-income minority children in urban areas often inhabit an environment that has excessive pollution and these children are at risk for obesity and poor diet.   Secondhand smoke (SHS) is a common exposure in homes of children in Baltimore City and approximately 50-80% of households have a smoker. Secondhand smoke has been associated with worse asthma outcomes.  We hypothesize that secondhand smoke exposure will be associated with increases in asthma morbidity and increases in systemic markers of inflammation and oxidative stress and that these responses will be exaggerated among overweight and obese children compared with normal weight and among those with poor diets compared to better diets among children with asthma.   Aim 1:  To investigate the effect of SHS exposure on asthma morbidity, systemic inflammation and oxidative stress among inner-city children with asthma. Hypotheses 1.Increasing SHS exposure will be associated with increases in asthma morbidity, systemic inflammation and oxidative stress. Aim 2: To determine if being overweight/obese modifies the effect of SHS exposure on respiratory symptoms, inflammation and oxidative stress responses among inner-city children with asthma.Hypothesis 2. SHS exposure will be associated with a worsened asthma and increases in systemic inflammation and oxidative stress among overweight/obese children compared to normal weight children. Aim 3: To determine if diet quality modifies the effect of SHS exposure on respiratory symptoms, inflammation and oxidative stress responses among inner-city children with asthma. Hypothesis 3. SHS smoke exposure will associated with worsened respiratory symptoms and increases in inflammation and oxidative stress among children with poor quality diet compared those with better quality diet inner-city children with asthma. (Diet will be assessed by dietary inflammatory index, healthy eating index, and additional serum markers proposed in this application).

PI(s): Meredith McCormack, MD, Johns Hopkins University

CHEAR Lab(s): M-CHEAR: Michigan Children's Health Exposure Analysis Resource Laboratory Hub, Minnesota CHEAR Exposure Assessment Hub

Related website and publications:
Validation of Detailed Maternal Cigarette Smoke Exposure Self Reporting by Cotinine Analysis

The Children’s Environment and Disease Prevention Research Center at Dartmouth utilizes a common longitudinal birth cohort study (New Hampshire Birth Cohort Study) begun in 2009 and comprised of more than 1,500 mother-child dyads who are residents of New Hampshire and obtain household water from private wells, a potential source of arsenic exposure in the region. Maternal participant age ranges from 18 to 45 years old and progeny age ranges from birth to 5 years. Objectives of the original study include 1) examining the effects of arsenic exposure during the vulnerable window of fetal development and early childhood upon childhood immunity, risk of infection, allergy/atopy, vaccine response and intestinal microbiome, 2) evaluate early childhood arsenic exposure via drinking water and diet and to quantify physical growth and neurodevelopmental effects of such exposures, and 3) develop novel biomarkers of exposure and health outcome by examining associations with epigenetic and gene expression profiles in infants and in placenta. The New Hampshire Birth Cohort Study obtains detailed information of maternal cigarette smoke exposure and second hand smoke exposure over the course of pregnancy and at child age of 5 years through self-reporting questionnaires. The study also collects maternal urine specimens between 22-30 weeks for subsequent analysis of biomarkers for various maternal exposures. The primary aim of the proposed request is to validate the NHBCS redundant self-reporting mechanisms of various cigarette smoke exposure by comparison to urinary biomarkers of i.e., cotinine and NNAL concentrations.

PI(s): Margaret Karagas, PhD, Geisel Dartmouth School of Medicine

CHEAR Lab(s): Minnesota CHEAR Exposure Assessment Hub

Related website and publications:
ECHO ReCHARGE Study - Environmental Exposures

The CHARGE (CHildhood Autism Risks from Genes and Environment) Study is a case-control investigation, initiated in 2003, of children with autism spectrum disorder (ASD), non-autistic developmental delay (DD), and typical development among population controls (TD). The ReCHARGE Study will follow-up CHARGE children who were recruited from areas surrounding the UC Davis MIND Institute in Sacramento. All children were born in California, living with a biologic parent who spoke English or Spanish, and enrolled in CHARGE at ages 2-5 years, at which time they were examined for neurodevelopmental status once. Over 80 of the ASD cases and their matched TD controls, and about 2/3 of the DD children are males. Approximately 30 were Hispanic; 16 black, Asian, or mixed race; and 54 white non-Hispanic. The CHEAR objective is to evaluate metals, pesticides, phthalates, phenols and perfluorinated concentrations for associations with ASD or DD diagnosis and cognitive function. Chemical-gene interactions will also be explored.

PI(s): Irva Hertz-Picciotto, PhD, University of California Davis

CHEAR Lab(s): Wadsworth Center's Children's Health Exposure Assessment Resource (WCCHEAR)

Related website and publications:
Pediatric Inner-City Environmental Exposures at School and Home and Asthma Study

Asthma affects 25 million Americans, particularly urban minority children. Children spend nearly all day in school, yet little is known about the role of a child’s exposure to widely disseminated industrial chemicals on asthma morbidity. Early animal models and population studies have begun to identify an association between phenolic chemical exposure and asthma development through proposed increased regulation of an individual’s allergic immune response. The study population consists of urban school children with physician diagnosis of asthma ages 4 through 13 from the Northeastern United States. In a cross sectional study, we hypothesize that exposure to environmental exposures (e.g. phenols, phthalates, and environmental tobacco smoke) in urban school children and higher urinary biomarkers will preliminarily be associated with higher asthma morbidity. This study, nested within a school-based environmental intervention trial, (School Inner-City Asthma Intervention Study, SICAS2 U01 AI 110397), will evaluate the impact of environmental and personal care product use exposures on these biomarker levels and the impact that these exposures have on asthma morbidity, controlling comprehensively for other personal, home, and school environmental factors associated with asthma outcomes.

PI(s): Wanda Phipatanakul, MD, Boston Childrens Hospital

CHEAR Lab(s): Minnesota CHEAR Exposure Assessment Hub, Mount Sinai CHEAR Network Laboratory Hub

Related website and publications:
Mitochondrial DNA biomarkers of prenatal metal mixture exposure: intergenerational inheritance and infant growth

"Project Viva is a prospective pre-birth cohort of mother-infant pairs, recruited in Eastern Massachusetts between 1999 and 2002 during the first prenatal visit at Atrius Harvard Vanguard Medical Associates. In-person visits with mothers were completed during the first (median 9.9 weeks of gestation) and second trimesters (median 27.9 weeks). We saw mothers and children in the hospital during the delivery admission and during infancy (median age 6.3 months). Follow-up visits have been completed in early childhood (median 3.2 years), mid-childhood (median 7.7 years), early adolescence (median 12.9 years) and currently a teenage follow-up visit is underway. Information was collected from mothers via interviews and questionnaires, performed anthropometric and neurodevelopmental assessments in children and collected bio-specimens in pregnancy and at each study visit. Our objective for this CHEAR project is to evaluate whether maternal prenatal exposure to metal mixtures in early pregnancy can disrupt molecular markers of mitochondrial DNA damage and abundance in mothers and children as a key mediator of metabolism and infant growth. Project Viva website: https://www.hms.harvard.edu/viva/

PI(s): Andres Cardenas, PhD, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute

CHEAR Lab(s): Mount Sinai CHEAR Network Laboratory Hub

Related website and publications:
Pulmonary Impact of NICU Exposures (PINE)

The original study, PROP, is a multi-center observational prospective cohort study that studies respiratory morbidity in pre-term infants. The current CHEAR study aims to characterize NICU-based phthalate exposure among pre-term infants enrolled in PROP. Additinally, the study will examine the relationship between NICU-based chemical exposure and pulmonary outcomes as well as between NICU-based phthalate exposure and biomarkers of oxidative stress.

PI(s): Annemarie Stroustrup, MD, Mount Sinai School of Medicine

CHEAR Lab(s): Mount Sinai CHEAR Network Laboratory Hub

Related website and publications:
Metabolomics Linking Air Pollution, Obesity and Type 2 Diabetes

Over the past 20 years, we have examined relationships between air pollution exposure and health outcomes in children in our longitudinal Children’s Health Study (CHS) starting in year 1993. Results from the CHS cohort have shown that near-roadway air pollution (NRAP) exposure is associated with increased risk of childhood obesity. Based on these findings, we are currently examining a subset of CHS participants (N=200) that represent extremes of NRAP exposure occurring in Southern California in the Southern California Children’s Environmental Health Center (SC-CEHC) Project 1 (the parent project), which capitalizes on CHS resources and extensive pollutant measurements to investigate the impact of lifetime air pollution exposures on obesity, fat distribution, glucose homeostasis, lipid profile, systemic inflammation and the metabolic syndrome at age 17-18 years. These participants are being extensively phenotyped for obesity using dual-energy X-ray absorptiometry (DXA) and magnetic resonance imaging (MRI). Glucose homeostasis is being assessed using an oral glucose tolerance test (OGTT). The proposed CHEAR project will support an innovative collaboration between the CHS and Emory’s CHEAR Laboratory Hub to perform non-targeted high resolution metabolomics (HRM) on 200 CHS fasting serum samples. The ultimate goal of this CHEAR project is to investigate the hypothesis that environmental chemicals, regional air pollutant (i.e. PM2.5) and traffic-related air pollution exposures (CALINE model-predicted NOx) can alter key metabolic pathway(s) and that these alterations are associated with obesity and type 2 diabetes-related traits during the important developmental period of adolescence.

PI(s): Frank Gilliland, MD, University of Southern California

CHEAR Lab(s): The National Exposure Assessment Laboratory at Emory

Related website and publications:
Role of environmental toxicants in modulating disease severity in children with NAFLD

Nonalcoholic fatty liver disease (NAFLD) is a global health problem, with prevalence estimated at 20% to 30% of the general population. There is not a good understanding of why some children progress to severe disease more rapidly. While it has been shown that genetic factors are contributors, there appears to be a strong modulation of the disease by environmental influences. Evidence exists demonstrating that toxins like perfluoroalkyl sulfonate (PFAS) surfactants may modulate lipoprotein metabolism and in mouse models, bisphenol A (BPA) induces epigenetic changes predisposing to NAFLD. We will use Children’s Health Exposure Analysis Resource (CHEAR) to further our understanding about how environmental toxicants modulate disease severity in children with NAFLD. The NASH Clinical Research Network (NASH CRN) was established in 2002 and has the largest, well characterized cohort of children with NAFLD who have blood samples acquired near in time to a liver biopsy, which is the most accurate way to assess NAFLD. Participants are at least 2 years of age and less than 18 years of age with liver biopsy proven NAFLD or NASH and collection of serum sample up to 90 days before or after the standard of care liver biopsy obtained.

PI(s): Ajay Jain, MD, Saint Louis University

CHEAR Lab(s): The National Exposure Assessment Laboratory at Emory

Related website and publications:
A Nested Case-Control Study of Prenatal Exposure to Phthalates and Psychosocial Stress: Adverse Pregnancy Outcomes and the Mediating Role of Placental Function

This study utilizes the Nulliparous Mothers to Be (nuMOM2be) cohort study, a nationally representative group of approximately 10,000 nulliparous women with detailed assessments, and biomarkers of urinary phthalates, inflammation and placental function during each trimester of pregnancy and at delivery. The CHEAR study will be a nested case control study of 1020 cases of Adverse Pregnancy Outcomes (APO’s). We examined associations between two classes of prenatal environmental exposures (phthalates and maternal stress) and APOs (spontaneous preterm birth and maternal hypertensive disorders of pregnancy). The overarching goals are (1) to provide more definitive data regarding the associations between prenatal phthalates, psychosocial stress and the APOs; (2) to provide mechanistic data (i.e. markers of inflammation and placental function) between these exposures and outcomes; (3) to provide an additional avenue to explore associations between these exposures and fetal growth, and determine whether APOs may mediate those relationships.

PI(s): Pam Factor-Litvak, PhD, Columbia University

CHEAR Lab(s): M-CHEAR: Michigan Children's Health Exposure Analysis Resource Laboratory Hub

Related website and publications:
Environmental phenols and pesticide levels in relationship to autism

The MARBLES Study is a cohort of high risk pregnancies for development of autism, typically a second child in a family that already has a child with autism. If there is already a child with autism in the family, the risk of another child with autism increases to approximately 20. Participating families reside in Northern California, specifically within a 2-hour drive of Sacramento. Mothers are enrolled either pre-conception or anytime during pregnancy. Children are followed until the child is three years old, at which time they receive a diagnosis of typically developing autism, or other developmental concerns. The study has been ongoing since 2006. In this Study, maternal urine samples from all three trimesters will be analyzed to determine concentrations of a suite of environmental phenols, including triclosan, triclocarbon, and BPA. Concentrations will be compared by diagnosis. First trimester samples will also be analyzed for metabolites of pesticides and phthalates.

PI(s): Deborah Bennett, PhD, University of California Davis

CHEAR Lab(s): The National Exposure Assessment Laboratory at Emory

Related website and publications:
Internal Metabolomic Biomarker Exposome and Developmental Disorders (IMBEDD)

The MARBLES (Markers of Autism Risk in Babies: Learning Early Signs) prospective study of over 450 high-risk pregnancies recruits mothers who have a child with confirmed ASD and are either planning a pregnancy or are pregnant with another child, in order to understand what influences the outcome of the younger sibling and to identify early markers of ASD. These younger siblings are at 13-fold higher risk for developing ASD (1:5), than children in the general population (1:68).MARBLES recruits Northern California families from lists of children receiving services through the California Department of Developmental Services, typically within two hours driving distance to the University of California Davis MIND Institute in Sacramento where clinical assessments are administered. The resulting study populations are racially, ethnically, and socioeconomically diverse. Children are followed until the child is three years old, at which time they receive a diagnosis of typically developing, autism, or other developmental concerns. Medical, nutritional, lifestyle, and contaminant exposure data, developmental assessments, and biologic specimens are collected periodically throughout pregnancy and the child’s first years. For this CHEAR study, metabolomic markers in child umbilical cord and maternal pregnancy EDTA plasma will be measured and compared across diagnostic outcomes to allow a comprehensive screen of compounds and/or pathways potentially associated with ASD.

PI(s): Rebecca J. Schmidt, PhD, University of California Davis

CHEAR Lab(s): The National Exposure Assessment Laboratory at Emory

Related website and publications:
Micronutrient deficiencies, environmental exposures and severe malaria: Risk factors for adverse neurodevelopmental outcomes in Ugandan children

The primary hypotheses is that zinc deficiency or exposure to heavy metals can influence short and long term neurocognitive outcomes in healthy community children and in children with severe malaria, and that children with cerebral malaria have specific metabolomic changes that relate to longterm neurocognitive impairment.The original study is a longitudinal cohort study of Ugandan children on the relationship between cerebral malaria (CM) and severe malarial anemia (SMA) on mortality (in hospital and during follow up) ( 2 yrs) and longterm neurodevelopment and behavior ( >5yrs). The CHEAR study will examine the effects of micronutrient deficiency, metal exposure, and inflammation or mortality and longterm neurodevelopment ( >5 yrs) and behavior in children with severe malaria (CM or SMA) and in community children (CC). There are measured levels of zinc, and heavy metals (lead, mercury, copper, manganese etc.) in children with severe malaria and community controls.

PI(s): Chandy C. John, MD, Indiana University School of Medicine

CHEAR Lab(s): The National Exposure Assessment Laboratory at Emory, Mount Sinai CHEAR Network Laboratory Hub

Related website and publications:
Sex-Specific Omics Profiles Related to Toxicant Exposures in Children

The objective of this project is to examine effects of toxicant exposures during three sensitive developmental timeframes – the prenatal period (during 1997-2004), early adolescence (8-14 years), and late adolescence (13-19 years) – on adiposity and metabolic risk in adolescence among participants of the Early Life Exposure to ENvironmental Toxicants (ELEMENT) Project, a Mexican birth cohort in Mexico City. We leverage existing data on toxicant exposure during all three timeframes, including bisphenol A (BPA), metals and phthalates, and propose to measure polycyclic aromatic hydrocarbon (PAH) metabolites in archived urine samples from the mothers and children. Additionally, we will carry out genome-wide DNA methylation analysis in peripheral leukocytes at all three timeframes, and untargeted metabolomics analyses in fasting serum during late adolescence to gain insight into molecular pathways linking exposure to each of these toxicants singly and as mixtures to health outcomes during adolescence. 

PI(s): Wei Perng, PhD, Department of Nutritional Sciences, University of Michigan School of Public Health

CHEAR Lab(s): M-CHEAR: Michigan Children's Health Exposure Analysis Resource Laboratory Hub

Related website and publications:
Relating Metals Exposure to Birth and Early Childhood Outcomes via the Metabotype of Cord Blood

The Proposed CHEAR study will study metals exposure in pregnant mothers to birth and early chidlhood outcomes in a Bangladeshi birth cohort. We will assess differences in anthropomorphic birth outcomes based on cord blood metabolite profiles acquired using a targeted 1H NMR-based platform. We will utilize established as well as novel analytic approaches in the field of metabolomics.

PI(s): David Christiani, MD, MPH, Harvard School of Public Health

CHEAR Lab(s): RTI CHEAR Exposure Assessment Hub

Related website and publications:
The Dynamics of Exposure, Phthalates and Asthma in a Randomized Trial (DEPART)

The Dynamics of Exposure, Phthalates, and Asthma project (DEPART) utilizes data and samples collected within the Home Air in Agriculture Pediatric Intervention Trial (HAPI, NIEHS R01 ES023510). The participants are 70 Latino children with asthma aged 6-12 years who reside in rural, agricultural central WA State. They were recruited from 2015-2017 for a one-year follow up period of their asthma morbidity following randomization into a control group (education) or intervention (education plus 2 in home portable HEPA air cleaners). Follow assessments include 2 time points prior to randomization and 2 post randomization and includes collection of urine specimens. DEPART’s objective is to examine associations between urinary biomarkers for emerging contaminants of concern – phthalates, pesticides, and phenols and biomarkers of oxidative stress and inflammation in this population. DEPART also includes metabolomic profiling to investigate potential additional biological mechanisms of toxicity associated with these exposures.

PI(s): Catherine Karr, MD, PhD, University of Washington

CHEAR Lab(s): Mount Sinai CHEAR Network Laboratory Hub

Related website and publications:
Microbial and metabolic variations mediate the influence of childhood and adolescent EDC and trace element exposure on breast density.

Our CHEAR project builds on the longitudinal Growth and Obesity Cohort Study in Santiago, Chile, which includes approximately 500 girls born in 2002-2003. Participants were recruited in 2006 from public nursery schools of six counties in Santiago representative of low to middle income families. Children were included if they were singletons with birthweight between 2500 and 4500g, and had no physical, medical or endocrine diseases that may alter the growth and/or onset of puberty. Semi-annual collection of participant anthropometric and pubertal development data by trained dietitians has continued since 2009. The overall objectives of our CHEAR study are to assess how exposure to endocrine-disrupting chemicals (phenols and phthalates), and trace elements (metals) measured in urine samples at Tanner stages 1 and 4 and 1 year post-menarche influence the pubertal microbiome and metabolome, and the potential impact on adolescent breast composition measured by DXA at Tanner stage 4 and 2 years post-menarche.

PI(s): Karin Michels, University of California Los Angeles

CHEAR Lab(s): The National Exposure Assessment Laboratory at Emory, Mount Sinai CHEAR Network Laboratory Hub

Related website and publications:
The impact of tobacco smoke exposure and environmental exposures on the pulmonary microbiome and outcomes of critically ill children

Ventilator-associated pneumonia (VAP) is a serious complication in mechanically ventilated children, increasing risk of mortality and morbidities including prolonged intubation and intensive care unit stays. Limited understanding of the microbial and host factors associated with VAP has precluded development of truly effective prevention and treatment strategies. We hypothesized that specific ecological patterns of the airway microbiome precede VAP and that the interaction of viral infection, bacterial populations, and the balance between host immune activation and immune suppression play crucial roles in determining whether a given patient develops VAP. We investigated this hypothesis with a prospective observational study with longitudinal (daily) examination of the airway microbiome in high risk mechanically ventilated children together with simultaneous proteomic assessments of the host immune response. Study participants were enrolled from 2015-2017 from participating sites in the NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN), including UCD/Children’s Hospital Colorado (Aurora, CO), UCSF Benioff Children’s Hospital (San Francisco, CA), UCLA Mattel Children’s Hospital (Los Angeles, CA), Children’s Hospital of Michigan (Detroit), Children’s Hospital of Philadelphia (Philadelphia, PA), Nationwide Children’s Hospital (Columbus, OH), Children’s National Medical Center (Washington, DC), University of Pittsburgh Children’s Hospital (Pittsburgh, PA). 455 subjects were enrolled between the ages of 31 days and 18 years. Subjects were followed throughout the hospital admission of their incident mechanical ventilation episode. The overall objective of the CHEAR project is to evaluate the effect of tobacco smoke exposure (TSE) and other environmental pollutant exposures on the composition and diversity of the bacteria in the lower airways in critically-ill, mechanically ventilated pediatric patients as well as the outcomes of these children.

PI(s): Peter Mourani, MD, University of Colorado Denver

CHEAR Lab(s): The National Exposure Assessment Laboratory at Emory

Related website and publications: